NASDAQ · Healthcare · Biotechnology
AbCellera Biologics Inc.
ABCL
AbCellera Biologics Inc. CEO Carl Hansen · Market cap $3.5B.
$11.32
-0.25 · -2.16%
52w hi $12.1552w lo $2.75
Off 52w high 1.0%
63
NOTABLE
Current InsiderScore
Corp · 90d
3
3 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
4
1 strong · 3 notable
Analyst consensus
Strong Buy
Avg PT $15.33
Section 01
Recent Form 4 filings
8 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Aug 18 | John S. Montalbano | Buy | 10,000 | $11.03 | +$110K | 36 | |
| Aug 14 | Andrew Booth | Chief Financial Officer | Buy | 37,200 | $10.32 | +$384K | 63 |
| Aug 12 | Michael R Hayden | Buy | 46,387 | $10.37 | +$481K | 54 | |
| May 14 | John S. Montalbano | Buy | 20,000 | $4.77 | +$95K | 36 | |
| Feb 27 | Andrew Booth | Chief Financial Officer | Buy | 42,600 | $3.42 | +$146K | 76 |
| Feb 27 | Thermopylae Holdings Ltd. | Buy | 38,000 | $3.44 | +$131K | 54 | |
| Feb 26 | Thermopylae Holdings Ltd. | Buy | 177,457 | $3.27 | +$580K | 67 | |
| Nov 26 | John S. Montalbano | Buy | 50,000 | $3.57 | +$178K | 60 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
SepOctNovDecJanFebMarAprMayJunJulAug